Martina Hahn

Karl Von Frisch Str. 2
Marburg An Der Lahn, HE 35043, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Developing a core competency framework for psychiatric pharmacists: a Europe-wide e-Delphi consensus study conducted by the European Society of Clinical Pharmacy Mental Health Special Interest Group.

Developing a core competency framework for psychiatric pharmacists: a Europe-wide e-Delphi consensus study conducted by the European Society of Clinical Pharmacy Mental Health Special Interest Group.

Journal: International journal of clinical pharmacy

Published: July 13, 2026

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Journal: Pharmacopsychiatry

Published: July 02, 2026

Therapeutic drug monitoring and pharmacogenomics: complementary tools in neuropsychopharmacology.

Therapeutic drug monitoring and pharmacogenomics: complementary tools in neuropsychopharmacology.

Journal: Current opinion in psychiatry

Published: May 19, 2026

Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment.

Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment.

Journal: Genes

Published: May 14, 2026

Analysis of drug-drug interactions between psychiatric drugs in spontaneous adverse drug reaction reports from EudraVigilance.

Analysis of drug-drug interactions between psychiatric drugs in spontaneous adverse drug reaction reports from EudraVigilance.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 12, 2025

Focusing on psychotropic drug interactions - Development of an 11-Item tool to compare interaction databases for psychiatric practice

Focusing on psychotropic drug interactions - Development of an 11-Item tool to compare interaction databases for psychiatric practice

Journal: Psychiatrische Praxis

Published: November 12, 2025

An Exploratory, Retrospective Study of the CYPRI Score for Pharmacogenetic Testing Among Mental Health Patients.

An Exploratory, Retrospective Study of the CYPRI Score for Pharmacogenetic Testing Among Mental Health Patients.

Journal: Genes

Published: October 21, 2025

CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing.

CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing.

Journal: The pharmacogenomics journal

Published: July 23, 2025

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study.

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study.

Journal: The pharmacogenomics journal

Published: April 08, 2025

Therapeutic Drug Monitoring of Cariprazine - Updated Values for a Dose-Related Reference Range.

Therapeutic Drug Monitoring of Cariprazine - Updated Values for a Dose-Related Reference Range.

Journal: Pharmacopsychiatry

Published: January 29, 2025

Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy's mental health specialist interest group.

Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy's mental health specialist interest group.

Journal: International journal of clinical pharmacy

Published: December 26, 2024

Correction: Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19

Correction: Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19

Journal: Fortschritte der Neurologie-Psychiatrie

Published: October 30, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026